Ostrander, OH, United States of America

Andrew R Eggers

This inventor holds 25 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents, primarily in Electrosurgical Instruments. Top assignees: Neothermia Corporation, Eggers & Associates, LLC, Arthrocare Corporation. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew R Eggers. Retrieved from https://idiyas.com/inventor/andrew-r-eggers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 92.0

 

Average Co-Inventor Count = 3.1

ph-index = 18

Forward Citations = 6,597(Granted Patents)


Location History:

  • Shade, OH (US) (2022 - 2023)
  • Ostrander, OH (US) (1996 - 2024)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Electrosurgery
Cardiac Shunts
Tissue Excision
Wearable Technology
Surgical Scalpel
Bipolar Instruments
Tissue Capture
Minimally Invasive
Monitoring Systems
Cauterization
Incisions
Emergency Response
25 patents (USPTO):Explore Patents

Title: Andrew R Eggers: Innovator in Cardiac Shunt Detection

Introduction

Andrew R Eggers, based in Ostrander, Ohio, is a prolific inventor with a total of 25 patents to his name. His innovative work primarily revolves around the field of cardiac health, where he has made significant contributions in the detection and quantification of right-to-left cardiac shunts.

Latest Patents

Eggers’ most recent patents include a groundbreaking system designed for the detection and quantification of the conductance of right-to-left cardiac shunts. This sophisticated system incorporates a mouthpiece assembly and a solenoid-driven vacuum/pressurization assembly, along with a controller for its operation. It features a monitor for displaying instructions and employs a microbubble counting cell combined with a digital image sensor paired with software-based image analysis. This technology is crucial in determining the number of microbubbles contained within a designated counting zone, thus being integral in medical diagnostics. Additionally, the system allows the operator to specify the total volume of contrast agent for injection, which is paramount for accurate assessments. The system also involves the strategic placement of Doppler ultrasound transducer arrays adjacent to targeted intracranial arteries to monitor the arrival of microbubble-containing contrast agents in the right atrium of the patient effectively.

Career Highlights

Andrew R Eggers has held pivotal roles in several companies within the industry, including Neothermia Corporation and Eggers & Associates, LLC. His contributions have significantly advanced technologies in medical diagnostics, particularly in innovations related to cardiac function.

Collaborations

Throughout his career, Eggers has collaborated with notable individuals such as Philip E Eggers and Eric A Eggers, enhancing the breadth of expertise and innovation in his projects. These collaborations have undoubtedly played a role in the successful development and patenting of his inventions.

Conclusion

Andrew R Eggers stands out as a leading figure in the realm of medical innovation, particularly regarding cardiac health technologies. With a robust portfolio of 25 patents, his advancements in the detection and quantification of cardiac shunts not only reflect his ingenuity but also promise to enhance patient care and diagnosis significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…